What is PHCRF stock price today?

PHCRF (Healius Limited) stock is trading at $0.84 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PHCRF stock going up or down today?

PHCRF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHCRF stock now?

The decision to buy PHCRF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHCRF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHCRF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHCRF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHCRF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHCRF's P/E ratio?

P/E ratio data for PHCRF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHCRF's market cap?

PHCRF (Healius Limited) has a market capitalization of $0.61 billion, making it a small-cap stock.

What is PHCRF's price to book ratio?

PHCRF trades at a price-to-book (P/B) ratio of 0.99, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PHCRF pay dividends?

PHCRF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHCRF's dividend yield?

PHCRF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHCRF stock a good long-term investment?

PHCRF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHCRF's revenue growth rate?

PHCRF has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

PHCRF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in PHCRF?

Key risks for PHCRF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHCRF compare to its competitors?

Compare PHCRF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHCRF's performance and positioning.

What is PHCRF's stock price target for 2026?

Our AI model provides price targets for PHCRF based on fundamental analysis: Bull case $1.09 (+30%), Base case $0.97 (+15%), Bear case $0.76 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PHCRF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHCRF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHCRF's next earnings report?

PHCRF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHCRF - Healius Limited

NYSE * Healthcare * Diagnostics & Research

$0.84

+$0.00 (+0.00%)

About Healius Limited

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

PHCRF Key Statistics

Market Cap

$609.95M

P/B Ratio

0.99

EPS

$-0.63

Revenue Growth

+0.0%

Profit Margin

-0.1%

Employees

3,699

How PHCRF Compares to Peers

PHCRF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHCRF(This stock)	$609.95M	N/A	0%	-0.1%	-
UNHUnitedhealth Group	$287.19B	23.9	0%	0.0%	vs UNH
JNJJohnson &	$565.22B	21.3	0%	0.2%	vs JNJ
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
PFEPfizer Inc	$154.84B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$369.65B	88.6	0%	0.1%	vs ABBV

Healius Limited Company Information

Headquarters: 161 Castlereagh Street, Sydney, NSW, Australia, 2000, undefined
Website: www.healius.com.au
Sector: Healthcare
Industry: Diagnostics & Research

About Healius Limited

PHCRF Key Statistics

How PHCRF Compares to Peers

Healius Limited Company Information

Upcoming Events for PHCRF